|
|
|
Volumn 16, Issue 9 Suppl 9, 2002, Pages 13-18
|
|
Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
IRINOTECAN;
RADIOSENSITIZING AGENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MULTIMODALITY CANCER THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SMALL CELL CARCINOMA;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0036726389
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (53)
|
